Dosing & administration for patients with EPI due to cystic fibrosis

CREON has multiple dosage strengths to help meet your patient’s changing lipase needs

CREON dosing should be individualized for each patient and adjusted based on clinical symptoms, degree of steatorrhea present, and dietary fat content.1

Chart for weight class and dosage for CREON® (pancrelipase) Delayed Release Capsules.

3,000

lipase units

Capsule with 3,000 lipase units.

6,000

lipase units

Capsule with 6,000 lipase units.

12,000

lipase units

Capsule with 12,000 lipase units.

24,000

lipase units

Capsule with 24,000 lipase units.

36,000

lipase units

Capsule with 36,000 lipase units.

Capsules shown are not actual size and do not represent the exact color shade. For illustrative purposes only. The active ingredient in CREON evaluated in clinical trials is lipase.

How soon do you follow up with patients after CREON treatment initiation?

You answered within the first month

Get educational resources, support program details, and prescription savings information.

Explore resources and support

You answered between 1 and 6 months

Review how to set treatment expectations with patients and what to discuss at follow-up appointments.

Hear from gastroenterologist Shahab Mehdizadeh, MD, as he shares CREON dosing tips.

You answered 6 months to a year

Review how to set treatment expectations with patients and what to discuss at follow-up appointments.

Hear from gastroenterologist Shahab Mehdizadeh, MD, as he shares CREON dosing tips.

You answered never

Review how to set treatment expectations with patients and what to discuss at follow-up appointments.

Hear from gastroenterologist Shahab Mehdizadeh, MD, as he shares CREON dosing tips.

Encourage your patients to fill out the Treatment Tracker and share it with you during their next appointment. This can help you assess how their treatment plan is going.

Get educational resources, support program details, and prescription savings information for your patients and practice.

CFF = Cystic Fibrosis Foundation; EPI = exocrine pancreatic insufficiency.